EUROPE NASAL SPRAY MARKET 2021-2028

Lifesciences | Pharmaceuticals

EUROPE NASAL SPRAY MARKET 2021-2028

Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s research report, the nasal spray market in Europe is expected to thrive at a CAGR of 8.35% during the estimated years from 2021 to 2028. 


Report scope can be customized per your requirements. Request For Customization

The countries sifted in this market include:

•        The UK

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

In the region, there is a high prevalence of nasal polyps and chronic rhinosinusitis. Further, the surge in the aging population has increased the burden of respiratory diseases to a large extent. Here, some of the major respiratory conditions include asthma, chronic obstructive pulmonary disease, respiratory allergies, and pulmonary hypertension. Besides, lung cancer has become a leading cause of death in the region. This surge in respiratory conditions has enhanced the demand for nasal sprays, which drives the development of the nasal spray market within Europe.

Given the UK market, respiratory diseases are the third major cause of death, including lung cancer, asthma, pneumonia, and others. Besides this, allergic rhinitis is highly prevalent, affecting 20% of the country’s population. Additionally, air pollution has become a significant problem leading to various health concerns, influencing the adoption of nasal sprays to treat various conditions. Hence, as mentioned above, the rise in respiratory diseases will ultimately augment the growth of the nasal spray market throughout the United Kingdom.

GlaxoSmithKline is a healthcare company engaged in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. Additionally, the company combines science and consumer insights to create healthcare brands for oral health, pain, cold, digestive health, and others. Its product line includes Otrivin Adult 0.1% Nasal Spray that offers effective relief from nasal congestion caused due to colds and allergies. The company is headquartered in the United Kingdom. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE NASAL SPRAY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1. ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2. UTILIZING NASAL SPRAY FOR DIABETES

2.2.3. ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. MERGERS & ACQUISITIONS

2.6.2. CONTRACTS & AGREEMENTS

2.6.3. DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2. INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3. GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1. COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1. APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2. USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3. EMPLOYING NASAL SPRAY AS A VACCINE

3. EUROPE NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4. EUROPE NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5. EUROPE NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6. EUROPE NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7. EUROPE NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8. EUROPE NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. UNITED KINGDOM

8.2. GERMANY

8.3. FRANCE

8.4. SPAIN

8.5. ITALY

8.6. RUSSIA

8.7. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10. PFIZER INC

9.11. PROCTOR AND GAMBLE CO

9.12. SANOTIZE RESEARCH AND DEVELOPMENT

9.13. SUN PHARMACEUTICALS INDUSTRIES LTD

9.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15. VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.2. SOURCES OF DATA

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: EUROPE NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: EUROPE NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: EUROPE NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: EUROPE NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: EUROPE NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: EUROPE NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: EUROPE NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: EUROPE NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED KINGDOM NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: GERMANY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: FRANCE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: SPAIN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: ITALY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: RUSSIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;